Vapotherm (VAPO) Misses Q1 EPS by 10c, Revenues Beat; Offers 2Q Revenue Guidance Above Consensus, Withdraws FY20 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Vapotherm (VAPO) Misses Q1 EPS by 10c, Revenues Beat; Offers 2Q Revenue Guidance Above Consensus, Withdraws FY20 Outlook

Vapotherm Reports First Quarter 2020 Financial Results

May 5, 2020 4:02 PM EDT

First Quarter 2020 Revenue of $19.1 Million Reflects 55.4% Increase Over Prior Year

EXETER, N.H.--(BUSINESS WIRE)-- Vapotherm, Inc. (NYSE: VAPO), (Vapotherm or the Company), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, today announced first quarter 2020 financial results.

First Quarter 2020 Summary

Revenue for the first quarter of 2020 was $19.1 million, representing a 55.4% increase over the prior year period Worldwide installed... More